15.05.2019 18:00:00
|
NEURONES : +4.2% organic growth in the 1st quarter 2019
PRESS INFORMATION
Nanterre, 15 May 2019 (after the closing of the stock exchange)
Heading: Revenues 1st quarter 2019
+4.2% organic growth in the 1st quarter 2019
(in millions of euros) | Q1 2018 | Q1 2019 | growth | of which organic |
Revenues (¹) | 124.1 | 128.7 | +3.7% | +4.2% |
Achievements
In the first quarter of 2019, the Group achieved 4.2% organic growth. Over the period, after the high point for financial year 2018, employee turnover began to decline.
The operating profit (¹) (²) for the quarter totaled 9.5% of revenues vs. 8.4% one year earlier.
Compared to the 2018 reference document (available at www.neurones.net), the financial situation did not experience any significant changes.
Outlook
In its current scope, NEURONES forecasts the following for 2019:
- close to €505 million in revenues,
- an operating profit (²) of between 9% and 9.5% of revenues.
(¹) Unaudited and after inclusion of 0.1% expenses related to bonus shares.
(²) These figures do not include the consolidated capital gain (+ €4.6 million) realized at the end of January 2019, on the occasion of the sale of an activity representing annual revenues of €5.3 million. The operating profit (IFRS) for the 1st quarter is therefore 13% and the forecast for financial year 2019 is increased by approximately 0.9% of revenues.
About NEURONES
With 5,200 experts, the NEURONES group specializes in Consulting (Management, Organization and Digital) and Digital Services (Infrastructures and Applications). It supports its clients in their digital transformation projects and in the upgrading of their information systems.
Euronext Paris (compartment B - NRO) - Enternext Tech 40 - SRD medium values
www.neurones.net
Investor Relations: NEURONES Paul-César Bonnel Tel: +33 (0)1 41 37 41 37 investisseurs@neurones.net | Press Relations: NEURONES Matthieu Vautier Tel: +33 (0)1 41 37 41 37 rp@neurones.net |
Attachment
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu NeuronesAct.mehr Nachrichten
Keine Nachrichten verfügbar. |